Clinical Trials Directory

Trials / Completed

CompletedNCT02087436

Taperloc Complete Microplasty vs Taperloc Complete Standard: Randomized Controlled Study on Bone Mineral Density

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Zimmer Biomet · Industry
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of this study is to measure the postoperative changes in bone mineral density, comparing the Taperloc Complete Reduced Distal Microplasty stem and the standard length Taperloc Complete Reduced Distal stem.

Detailed description

The Taperloc Microplasty cementless stem is designed to transmit load to the proximal femur, thereby preserving bone density, and preventing long term instability and loosening secondary to proximal bone resorption. The primary aim of this study is therefore to compare the postoperative changes in bone density with the Taperloc Microplasty stem, using the standard length Taperloc stem as a control. In addition, the Taperloc stem has historically had a neck angle of 138°. There have been criticisms that this neck angle is too high for the typical Korean population. The newer Taperloc Complete system (both Microplasty and standard length) has a neck angle of 133°. A secondary aim is Occurrence ratio of thigh pain difference between Microplasty and standard stem in Korean Population

Conditions

Interventions

TypeNameDescription
DEVICETaperloc Complete MicroplastyTaperloc Complete Microplsty cementless stem is designed to transmit load to the proximal femur, thereby preserving bone density, and preventing long term instability and loosening secondary to proximal bone resorption.
DEVICETaperloc Complete StandardTaperloc Complete Standard is designed after the philosophy of a flat tapered wedge. It has evolved to incorporate the Reduced Distal and Microplasty stems to better address all patient anatomies, and facilitate multiple surgical techniques.

Timeline

Start date
2013-03-01
Primary completion
2014-07-01
Completion
2019-12-01
First posted
2014-03-14
Last updated
2020-01-09

Locations

2 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02087436. Inclusion in this directory is not an endorsement.